American Century Companies Inc. Has $1.94 Million Holdings in Kewaunee Scientific Corporation $KEQU

American Century Companies Inc. increased its position in Kewaunee Scientific Corporation (NASDAQ:KEQU - Free Report) by 43.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,182 shares of the technology company's stock after purchasing an additional 14,889 shares during the quarter. American Century Companies Inc. owned approximately 1.72% of Kewaunee Scientific worth $1,937,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bank of America Corp DE lifted its position in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc lifted its position in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock worth $37,000 after purchasing an additional 360 shares during the period. Jane Street Group LLC bought a new position in Kewaunee Scientific in the fourth quarter worth $300,000. Finally, Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 42.2% in the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after purchasing an additional 5,330 shares during the period. 32.69% of the stock is owned by institutional investors.

Kewaunee Scientific Price Performance

Shares of NASDAQ KEQU traded down $0.38 during midday trading on Friday, reaching $53.73. 5,808 shares of the company traded hands, compared to its average volume of 6,423. The firm has a market cap of $158.50 million, a PE ratio of 14.03 and a beta of 0.75. The stock's 50-day simple moving average is $56.75 and its 200-day simple moving average is $46.03. Kewaunee Scientific Corporation has a 12 month low of $30.33 and a 12 month high of $71.33. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.59 and a current ratio of 2.20.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings data on Wednesday, June 25th. The technology company reported $1.95 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 26.02% and a net margin of 4.74%.The company had revenue of $77.15 million during the quarter.

Analyst Ratings Changes

Separately, Wall Street Zen raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.

Insiders Place Their Bets

In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 3,000 shares of the firm's stock in a transaction dated Thursday, July 24th. The shares were sold at an average price of $58.59, for a total value of $175,770.00. Following the completion of the sale, the chief financial officer owned 14,564 shares in the company, valued at approximately $853,304.76. This trade represents a 17.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 13.30% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.